DoxyPEP in 2026: Who Benefits, How to Prescribe, and What to Watch
April 2025
Click for full info +Full Info:
Resource Type:
Citation:
Authors: Lima, D. B.
Health Risks(s):
- Chlamydia
- Gonorrhea
- STI / STD
Product type(s):
- MPTs
- Other
Topic(s):
- Product Introduction
- Regulatory
Working Group
- STI
Region(s)
- Global
Additional Keywords:
doxyPEP; doxycycline; post-exposure prophylaxis; STI prevention; syphilis; chlamydia; gonorrhea; CDC guidance